MARKET

PGEN

PGEN

Precigen Inc
NASDAQ
4.160
-0.030
-0.72%
After Hours: 4.120 -0.04 -0.96% 17:12 12/26 EST
OPEN
4.170
PREV CLOSE
4.190
HIGH
4.240
LOW
4.050
VOLUME
2.82M
TURNOVER
--
52 WEEK HIGH
5.23
52 WEEK LOW
0.6916
MARKET CAP
1.47B
P/E (TTM)
-2.9699
1D
5D
1M
3M
1Y
5Y
1D
Director and 10% Owner Randal J. Kirk Reports Sale of Precigen Inc. Common Shares
Reuters · 4d ago
Weekly Report: what happened at PGEN last week (1215-1219)?
Weekly Report · 5d ago
Trade Alert: Independent Director Of Precigen Jeffrey Kindler Has Sold Stock
Simply Wall St · 12/18 11:10
Director’s Major Stock Sale Shakes Up Precigen!
TipRanks · 12/17 02:08
Precigen Director Jeffrey B. Kindler Reports Sale of Common Shares
Reuters · 12/16 21:17
Spotlighting Bridgewater Bancshares And 2 Other Growth Stocks With Strong Insider Ownership
Simply Wall St · 12/16 11:05
Weekly Report: what happened at PGEN last week (1208-1212)?
Weekly Report · 12/15 10:43
Weekly Report: what happened at PGEN last week (1201-1205)?
Weekly Report · 12/08 10:42
More
About PGEN
Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company developing gene and cell therapies for improving outcomes for patients with unmet medical needs. The Company’s proprietary technology platforms develop product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company’s segments include Biopharmaceuticals and Exemplar. The Biopharmaceuticals segment is primarily comprised of the Company's legal entities as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. The Exemplar is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar, its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Webull offers Precigen Inc stock information, including NASDAQ: PGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGEN stock methods without spending real money on the virtual paper trading platform.